FAM135B: A Potential Drug Target Or Biomarker (G51059)
FAM135B: A Potential Drug Target Or Biomarker
FAM135B (FAM135B variant 1) is a gene that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its unique genetic variation has led to the development of a new variant, FAM135B variant 2, which has been shown to have improved efficacy in clinical trials for some cancer treatments.
FAM135B is a gene that encodes a protein known as FAM135B, which is a key regulator of the microtubules in cells. Microtubules are dynamic structures that play a crucial role in the movement of cells, the transport of materials within cells, and the regulation of cell division. FAM135B is a protein that helps to control the formation and stability of microtubules, which is essential for the proper functioning of cells.
The FAM135B gene has been associated with various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. For example, studies have shown that individuals with certain genetic variations in the FAM135B gene are at increased risk of developing certain types of cancer. Additionally, FAM135B has been implicated in the development of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.
One of the most promising aspects of FAM135B is its potential as a drug target or biomarker. By targeting the FAM135B protein, researchers can potentially develop new treatments for various diseases. For example, studies have shown that inhibiting FAM135B, using a small molecule inhibitor, can significantly improve the efficacy of certain cancer treatments. This suggests that FAM135B may be a valuable target for cancer treatments.
In addition to its potential as a drug target, FAM135B is also a promising biomarker for certain diseases. Its unique genetic variation has led to the development of a new variant, FAM135B variant 2, which has been shown to have improved efficacy in clinical trials for some cancer treatments. This suggests that FAM135B may be a valuable biomarker for certain types of cancer, and that its levels or activity may be a useful indicator of disease status.
Overall, FAM135B is a gene that has the potential to be a drug target or biomarker for various diseases. Its unique genetic variation and association with various diseases make it an attractive target for research into the underlying mechanisms of these conditions. Further studies are needed to fully understand the potential of FAM135B as a drug target or biomarker.
Protein Name: Family With Sequence Similarity 135 Member B
More Common Targets
FAM136A | FAM136BP | FAM138A | FAM138B | FAM138C | FAM138D | FAM138F | FAM13A | FAM13A-AS1 | FAM13B | FAM13C | FAM149A | FAM149B1 | FAM151A | FAM151B | FAM153A | FAM153B | FAM153CP | FAM156A | FAM157A | FAM157B | FAM157C | FAM161A | FAM161B | FAM162A | FAM162B | FAM163A | FAM163B | FAM166A | FAM166B | FAM166C | FAM167A | FAM167A-AS1 | FAM167B | FAM168A | FAM168B | FAM169A | FAM169BP | FAM170A | FAM170B | FAM170B-AS1 | FAM171A1 | FAM171A2 | FAM171B | FAM172A | FAM172BP | FAM174A | FAM174B | FAM174C | FAM177A1 | FAM177B | FAM178B | FAM180A | FAM180B | FAM181A | FAM181B | FAM182A | FAM182B | FAM183A | FAM183BP | FAM184A | FAM184B | FAM185A | FAM185BP | FAM186A | FAM186B | FAM187B | FAM187B2P | FAM193A | FAM193B | FAM197Y2 | FAM199X | FAM200A | FAM200B | FAM200C | FAM201A | FAM204A | FAM205A | FAM205BP | FAM207BP | FAM209A | FAM209B | FAM20A | FAM20B | FAM20C | FAM210A | FAM210B | FAM215A | FAM216A | FAM216B | FAM217A | FAM217B | FAM218A | FAM219A | FAM219B | FAM21B | FAM21EP | FAM220A | FAM220BP | FAM221A